Technology
Live Price
Offline$12.83
+2.89% today
1Y Change
-23.52%
Window
Jun 25, 2025 โ Jun 22, 2026
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cellebrite DI Ltd. (CLBT) is a Technology stock with a market cap of $3.39B and listed on NASDAQ. The stock last traded around $12.83 and down 23.5% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +18.6%, EPS growth of +123.7%, a dividend yield of 0.0%. What stands out right now is revenue +18.6%, EPS +123.7%, free cash flow +28.1% with operating margin 14.0% and ROIC 10.0%. Valuation already assumes a fairly strong business story at P/E 46.1 and price/sales 7.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CLBT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+18.6% vs +11.9% peer median
Operating Margin
Below sector median
+14.0% vs +22.0% peer median
P/E
Above sector median
46.1 vs 18.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +18.6% and EPS at +123.7%, with operating margin around 14.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +6.0% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | โ | +8.4% | +10.7% | +6.1% |
2026 Feb 11, 2026 | -35.7% | -3.9% | -3.4% | +1.9% |
2025 Nov 12, 2025 | +48.2% | +20.7% | +10.6% | +19.3% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CLBT
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CLBT Max Drawdown
-43.61%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CLBT and SPY.
Company Overview
Cellebrite DI Ltd.
NASDAQ
Cellebrite DI Ltd. is an Israeli digital intelligence company headquartered in Petah Tikva, providing advanced solutions for legally sanctioned digital investigations worldwide. Its core offerings include the DI suite, which enables users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle from sources like mobile devices, computers, drones, SIM cards, GPS devices, social media, and cloud platforms. Notable products such as Inseyets facilitate the collection and review of digital evidence, while tools like the Universal Forensic Extraction Device (UFED) support extraction from a wide array of devices, including those with advanced security like Apple T2 chips. Cellebrite DI Ltd. serves law enforcement at federal, state, and local levels, military and intelligence agencies, immigration authorities, prison systems, and enterprise customers tackling cases involving child exploitation, homicide, terrorism, organized crime, human trafficking, corporate security, cryptocurrency investigations, and intellectual property theft. The company also delivers analytics, training, and services to enhance efficiency in public safety and private sector operations, positioning it as a leader in digital forensics and investigative technologies.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.